Completed NA INTERVENTIONAL 1-arm NCT00288977

Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants

Islet Transplantation in Type 1 Diabetic Recipients of Renal Allografts, Using the Edmonton Protocol

Sponsor: Beth Israel Deaconess Medical Center

Conditions Diabetes Kidney Transplantation

Updated 6 times since 2017 Last updated: Mar 14, 2017 Started: Sep 30, 2000 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00288977, this NA trial focuses on Diabetes and Kidney Transplantation and remains completed. Sponsored by Beth Israel Deaconess Medical Center, it has been updated 6 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Apr 2017 — Jun 2018 [monthly]

Completed NA

Phase: PHASE2_PHASE3 → NA

▶ Show 1 earlier version

Jan 2017 — Apr 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

Sep 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center
Joslin Diabetes Center

Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.